Squarepoint’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Buy |
167,814
+105,487
| +169% | +$1.48M | ﹤0.01% | 1104 |
|
|
2025
Q1 | $975K | Sell |
62,327
-59,065
| -49% | -$924K | ﹤0.01% | 1528 |
|
|
2024
Q4 | $1.69M | Buy |
121,392
+48,769
| +67% | +$679K | ﹤0.01% | 1247 |
|
|
2024
Q3 | $675K | Buy |
+72,623
| New | +$675K | ﹤0.01% | 1621 |
|
|
2024
Q2 | – | Sell |
-205,870
| Closed | -$2.04M | – | 2475 |
|
|
2024
Q1 | $2.04M | Buy |
205,870
+56,447
| +38% | +$559K | ﹤0.01% | 1025 |
|
|
2023
Q4 | $483K | Buy |
149,423
+90,565
| +154% | +$293K | ﹤0.01% | 1713 |
|
|
2023
Q3 | $313K | Buy |
+58,858
| New | +$313K | ﹤0.01% | 1904 |
|
|
2023
Q1 | – | Sell |
-36,227
| Closed | -$536K | – | 2252 |
|
|
2022
Q4 | $536K | Buy |
36,227
+20,946
| +137% | +$310K | ﹤0.01% | 1422 |
|
|
2022
Q3 | $292K | Buy |
+15,281
| New | +$292K | ﹤0.01% | 1641 |
|
|
2021
Q2 | – | Sell |
-10,649
| Closed | -$308K | – | 2601 |
|
|
2021
Q1 | $308K | Sell |
10,649
-38,433
| -78% | -$1.11M | ﹤0.01% | 1854 |
|
|
2020
Q4 | $1.38M | Buy |
+49,082
| New | +$1.38M | 0.01% | 915 |
|
|
2020
Q3 | – | Sell |
-12,422
| Closed | -$376K | – | 2315 |
|
|
2020
Q2 | $376K | Buy |
+12,422
| New | +$376K | 0.01% | 1443 |
|